Evidence map›Paper›PMID 41776061›Full record

ReviewNPJ cardiovascular health2024

Circadian rhythms in cardiovascular (dys)function: approaches for future therapeutics.

Margaux Lecacheur, Daniëlle J M Ammerlaan, Pieterjan Dierickx

Abstract readReview
In one paragraph

Review in NPJ cardiovascular health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. The ClockJournal of orthopaedic surgery and research · 2026
    Article
  6. Review
  7. The CLOCK-BMAL1 complex in circadian regulation: structure, mechanisms, and therapeutic targeting.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. NADCommunications biology · 2026
    Article
  13. Impact of E-Cigarette Use on Circadian Proteins and Cardiovascular Risk Markers.Journal of cardiovascular translational research · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Margaux Lecacheur *Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Daniëlle J M Ammerlaan *Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
Pieterjan DierickxMax Planck Institute for Heart and Lung Research, Bad Nauheim, Germany. pieterjan.dierickx@mpi-bn.mpg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The circadian clock is an evolutionarily conserved time-keeper that regulates physiological processes across 24 h. In the cardiovascular system, several parameters, such as blood pressure, heart rate, and metabolism, exhibit time-of-day variations. These features are in part driven by the circadian clock. Chronic perturbation of diurnal rhythmicity due to shift work or irregular social schedules has been associated with an increased risk of hypertension, arrhythmias, and myocardial infarction. This review discusses the impact of circadian rhythms on human cardiovascular health and the effect of clock disruption on the occurrence of adverse cardiac events. Additionally, we discuss how the main risk factors of cardiovascular diseases, such as obesity, sleep disorders, and aging, affect circadian rhythms. Finally, we elaborate on chronotherapy as well as on targeting the clock and highlight novel approaches to translate our scientific understanding of the circadian clock into clinical practice.

Identifiers

PMID41776061
PMCPMC12912364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.